Aberdeen Group plc Purchases 2,319 Shares of National Health Investors, Inc. $NHI

Aberdeen Group plc grew its holdings in National Health Investors, Inc. (NYSE:NHI) by 9.1% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 27,686 shares of the real estate investment trust’s stock after purchasing an additional 2,319 shares during the quarter. Aberdeen Group plc’s holdings in National Health Investors were worth $1,941,000 as of its most recent filing with the SEC.

A number of other institutional investors have also made changes to their positions in the business. Monument Capital Management acquired a new position in shares of National Health Investors during the 2nd quarter worth about $252,000. Woodmont Investment Counsel LLC boosted its position in shares of National Health Investors by 33.4% in the second quarter. Woodmont Investment Counsel LLC now owns 77,705 shares of the real estate investment trust’s stock valued at $5,449,000 after acquiring an additional 19,444 shares during the period. Mirae Asset Global Investments Co. Ltd. boosted its position in shares of National Health Investors by 267.4% in the second quarter. Mirae Asset Global Investments Co. Ltd. now owns 4,508 shares of the real estate investment trust’s stock valued at $316,000 after acquiring an additional 3,281 shares during the period. Sound Income Strategies LLC grew its stake in shares of National Health Investors by 8.3% in the second quarter. Sound Income Strategies LLC now owns 230,690 shares of the real estate investment trust’s stock worth $16,176,000 after acquiring an additional 17,608 shares during the last quarter. Finally, Ausbil Investment Management Ltd bought a new position in National Health Investors during the second quarter worth $356,000. 62.51% of the stock is currently owned by institutional investors.

National Health Investors Price Performance

National Health Investors stock opened at $75.39 on Friday. The business’s fifty day moving average is $77.07 and its two-hundred day moving average is $74.09. The company has a debt-to-equity ratio of 0.75, a quick ratio of 10.91 and a current ratio of 10.91. The firm has a market cap of $3.58 billion, a P/E ratio of 24.09, a P/E/G ratio of 3.36 and a beta of 0.77. National Health Investors, Inc. has a 52 week low of $65.13 and a 52 week high of $82.32.

National Health Investors (NYSE:NHI) last issued its quarterly earnings data on Wednesday, August 6th. The real estate investment trust reported $1.22 EPS for the quarter, topping analysts’ consensus estimates of $1.16 by $0.06. National Health Investors had a net margin of 40.97% and a return on equity of 10.32%. The firm had revenue of $70.27 million for the quarter, compared to analyst estimates of $86.46 million. During the same quarter in the prior year, the firm earned $1.18 EPS. The company’s revenue was up 6.7% on a year-over-year basis. Equities research analysts forecast that National Health Investors, Inc. will post 4.41 earnings per share for the current fiscal year.

National Health Investors Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Tuesday, September 30th will be paid a $0.92 dividend. The ex-dividend date of this dividend is Tuesday, September 30th. This is a boost from National Health Investors’s previous quarterly dividend of $0.90. This represents a $3.68 dividend on an annualized basis and a yield of 4.9%. National Health Investors’s payout ratio is 117.57%.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on NHI. Truist Financial increased their price target on shares of National Health Investors from $77.00 to $81.00 and gave the company a “buy” rating in a report on Friday, August 15th. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of National Health Investors in a research report on Wednesday, October 8th. National Bankshares set a $90.00 target price on National Health Investors in a research report on Wednesday, October 1st. Wells Fargo & Company boosted their price target on National Health Investors from $76.00 to $80.00 and gave the company an “equal weight” rating in a research note on Wednesday, August 27th. Finally, Wedbush raised National Health Investors to a “strong-buy” rating in a report on Wednesday, July 2nd. One analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Buy” and a consensus target price of $84.83.

National Health Investors Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.